Pharmaceuticals

Real talk from the front lines of today’s research and manufacturing landscape

Decades of scientific progress in understanding the root cause of many formerly intractable diseases has opened up new treatment options, namely through RNA-based therapies. This second wave of biopharma, in which our understanding of the ways coding portions of our genome relate to disease, allows us to intercede earlier, and at more specific and effective junctures.

The top trends for plasma protein manufacturing are driven by a need to meet greater global demand in the face of a plasma shortage.

Changing the way therapies work, and the changing work of making therapies.

To bring the exciting science of cell and gene therapy manufacturing to life, creating smaller-scale filling solutions is imperative to the success of the ATMP industry. But before you begin scaling your operation, there are important questions to consider about fill-finish in ATMP.

Spray drying is a rapid, robust, reproducible, and scalable process.

Creating a roadmap to the digitalization of your next pharmaceutical facility.

New uses for oligonucleotides and increasing demand are driving oligo manufacturers to scale up to commercial production.